The store will not work correctly when cookies are disabled.
2-(2-methoxyhenicosyl)pyridine
ID: ALA4789801
PubChem CID: 162669717
Max Phase: Preclinical
Molecular Formula: C27H49NO
Molecular Weight: 403.70
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCCCCCCCCCCCCCCC(Cc1ccccn1)OC
Standard InChI: InChI=1S/C27H49NO/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23-27(29-2)25-26-22-20-21-24-28-26/h20-22,24,27H,3-19,23,25H2,1-2H3
Standard InChI Key: MOFARMJVPKYPEN-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 29 0 0 0 0 0 0 0 0999 V2000
6.8928 -3.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6073 -2.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6073 -1.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8928 -1.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1783 -1.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1783 -2.6125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8928 -3.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6073 -4.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6073 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3217 -5.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0362 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7507 -5.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4652 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1796 -5.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8941 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6086 -5.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3230 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0375 -5.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7520 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4665 -5.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1809 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8954 -5.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6099 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3243 -5.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0388 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7533 -5.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4678 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3217 -3.8500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0362 -4.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
28 29 1 0
8 28 1 0
1 7 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 403.70 | Molecular Weight (Monoisotopic): 403.3814 | AlogP: 8.68 | #Rotatable Bonds: 21 |
Polar Surface Area: 22.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 5.22 | CX LogP: 9.45 | CX LogD: 9.44 |
Aromatic Rings: 1 | Heavy Atoms: 29 | QED Weighted: 0.19 | Np Likeness Score: -0.01 |
References
1. Kouba S,Braire J,Félix R,Chantôme A,Jaffrès PA,Lebreton J,Dubreuil D,Pipelier M,Zhang X,Trebak M,Vandier C,Mathé-Allainmat M,Potier-Cartereau M. (2020) Lipidic synthetic alkaloids as SK3 channel modulators. Synthesis and biological evaluation of 2-substituted tetrahydropyridine derivatives with potential anti-metastatic activity., 186 [PMID:31753515] [10.1016/j.ejmech.2019.111854] |